In Brief: Advanced Tissue Sciences' Dermagraft
This article was originally published in The Gray Sheet
Executive Summary
Advanced Tissue Sciences' Dermagraft: Bioengineered living human dermal tissue product will be reviewed for treatment of diabetic foot ulcers by FDA's General and Plastic Surgery Devices Panel at a Jan. 29-30 meeting, the company reports. A December 1996 premarket approval application for the indication has been granted accelerated review by FDA ("The Gray Sheet" Dec. 23, 1996, In Brief). Smith & Nephew plc is ATS' marketing partner...